The purpose of this study is to determine whether anti-testosterone medications, when
administered before, during, and after high-dose, precision radiation, will be effective in
preventing the prostate cancer from returning.
Phase:
Phase 2
Details
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborators:
Janssen Pharmaceuticals University of Michigan Weill Medical College of Cornell University